Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,525.47
(
-1.23%
)
US TECH 100
23,356.00
(
-1.54%
)
Dow Jones
45,656.68
(
-0.79%
)
Brent Oil
107.15
(
2.60%
)
Bitcoin
69,910.00
(
0.02%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11870
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: masterlongevity post# 144148

Wednesday, 06/20/2012 1:41:03 PM

Wednesday, June 20, 2012 1:41:03 PM

Post# of 257262
Bapineuzumab data to be presented at meeting in October
The American Neurological Assocation's 2012 annual meeting schedule indicates Phase III study results of Bapineuzumab, produced by Elan (ELN), Johnson & Johnson (JNJ), Pfizer (PFE), will be presented on October 8. A spokeswoman for Johnson & Johnson confirmed to Bloomberg the Alzheimer’s drug results will be presented at the annual meeting being held from October 7-9. :thefly
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today